New Smart Labels Have Targeted GLP-1 Pen Security
New anti-counterfeiting labels for GLP-1 injectors use digital and physical features to verify authenticity.
Updated on Sept. 24, 2026 in Diabetes
Live Poll
Do you trust pharmaceutical companies to successfully use new technology to prevent drug counterfeiting?
Schreiner MediPharm has developed a multifunctional label for GLP-1 drug pens and autoinjectors designed to prevent counterfeiting. These smart labels are intended to protect patients and ensure the authenticity of medications used to treat diabetes and obesity.
Why it matters
The surging global demand for GLP-1 medications has made these injectable products prime targets for counterfeiters. This technology aims to secure the pharmaceutical supply chain by helping to ensure that the medication patients receive is legitimate and untampered.
The new labeling system incorporates both physical and digital verification methods, including ShiftSecure, InfraredSecure, and smartphone-readable NFC technology. While these features are designed to prevent product tampering, long-term impact on global counterfeit rates remains unknown.
The players
Schreiner MediPharm
A developer of specialized labeling solutions and security technology for the pharmaceutical industry.
The details
The label uses overt visual effects that change based on the viewing angle, alongside semi-covert microtext and infrared security features. Its design includes a physical component that covers the pen cap, leaving behind visible printed residue if the packaging is tampered with or removed prematurely. Additionally, the integration of smartphone-readable NFC chips allows users to authenticate the product and potentially access digital support services.
Timeline
September 24, 2026: Publication of the announcement regarding new label technology.
Health Landscape
The rise of GLP-1 drugs for diabetes and obesity has transformed the medical landscape, leading to unprecedented global demand. This labeling innovation represents a direct response to the supply chain vulnerabilities that have emerged alongside this rapid clinical adoption.
Patients using injectable GLP-1 pens should remain vigilant about the physical appearance and seal integrity of their medication devices. If you ever have concerns about the authenticity or condition of your medication, verify the packaging and consult your doctor or pharmacist immediately.
The takeaway
Counterfeit medications pose significant health risks, especially for those managing complex conditions like diabetes. Always inspect your medication packaging for signs of tampering, such as damaged seals or missing labels, and discuss any suspicious findings with your prescribing physician.
Further reading
For more on how new technologies and treatments are shaping care, visit our Diabetes section.
Source note: This article includes information reported by Labelsandlabeling.
Live Poll
Do you trust pharmaceutical companies to successfully use new technology to prevent drug counterfeiting?
